1644P Efficacy and safety of RP1 plus nivolumab in patients with advanced anti–PD-1-failed acral melanoma

作者：C. Robert, J.J. Sacco, E. Muñoz-Couselo, D. Schadendorf, G.K. In, Georgia M. Beasley, Jiaxin Niu, Bartosz Chmielowski, T.M. Wise-Draper, M.M. Milhem, Tawnya L. Bowles, Katy K. Tsai, C. Lebbé, C. Gaudy Marqueste, Adel Samson, Junhong Zhu, Marta Viana, Jundi Hou, Michael K. Wong · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.08.2272 · 研究领域：Cancer Immunotherapy and Biomarkers、Melanoma and MAPK Pathways、Cutaneous Melanoma Detection and Management